Strategic approaches to improving risk management in pharmaceutical organizations

Abstract

The effective functioning of pharmaceutical organizations in conditions of high market volatility, regulatory changes and globalization challenges directly depends on the quality of the risk management system. The specificity of the pharmaceutical industry, which is associated with strict requirements for safety, quality (GMP/GDP) and efficacy of medicines, requires the transformation of traditional reactive approaches to risk management into proactive strategic models. The implementation of integrated risk management allows not only to minimize potential losses at all stages of the product life cycle, but also to ensure the sustainable competitiveness of the enterprise.